Company Overview
Snapshot
Founded in March 2020 by Amir Nathan, Sequel.Care operates with 11–50 employees. The company has raised $2.85M across four funding rounds from two investors, with Alon MedTech Ventures participating in a Pre-Seed round in January 2022.
Business overview
Sequel.Care develops a digital therapeutics platform designed to empower clinicians with data-driven decision-making and therapy tools for optimizing mental health treatment. Its core technology focuses on personalizing treatment, identifying relapse, and facilitating therapeutic and digital interventions throughout the patient journey. The company serves healthcare providers, insurance companies, and pharmaceutical companies, operating within the digital healthcare sector with a focus on mental health and digital therapeutics in North America, the United States, and Israel.
Log in to access full profile ›Company Intelligence Q&A
- When was Sequel.Care founded?
- Sequel.Care was founded in March 2020 by Amir Nathan.
- What is Sequel.Care's primary focus?
- Sequel.Care focuses on empowering clinicians with data-driven decision-making and therapy tools to optimize mental health treatment, engage patients, and enhance collaboration for superior clinical outcomes.
- How much capital has Sequel.Care raised to date?
- Sequel.Care has raised a total of $2.85M across 4 funding rounds.
- Has Sequel.Care received any grants?
- Yes, Sequel.Care received a grant from the Office of the Chief Scientist in October 2024 and another in July 2022.